12
Views
4
CrossRef citations to date
0
Altmetric
Original article

Antifibrinolytic proCPU is present in the peritoneal cavity during surgery

, , , , , , & show all
Pages 287-296 | Received 19 Feb 2003, Accepted 22 May 2003, Published online: 08 Jul 2009

REFERENCES

  • Menzies D. Postoperative adhesions: their treat-ment and relevance in clinical practice. Ann R Coll Surg Engl 1993; 75: 147–53.
  • Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, Van Goor H. Morbidity and mortality of inad-vertent enterotomy during adhesiotomy. Br J Surg 2000; 87: 467–71.
  • Holmdahl L, Eriksson E, al-Jabreen M, Risberg B. Fibrinolysis in human peritoneum during opera-tion. Surgery 1996; 119: 701–5.
  • Sakharov DV, Plow EF, Rijken DC. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem 1997; 272: 14477–82.
  • Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996; 271: 16603–8.
  • Marx PF, Wagenaar GT, Reijerkerk A, Tiekstra MJ, van Rossum AG, Gebbink MF, Meijers JC. Characterization of mouse thrombin-activatable fibrinolysis inhibitor. Thromb Haemost 2000; 83: 297–303.
  • van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. Characteriza-tion and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothe-lial cells. Blood 1990; 75: 1490–7.
  • Ivarsson ML, Falk P, Holmdahl L. Response of visceral peritoneum to abdominal surgery. Br J Surg 2001; 88: 148–51.
  • Stromqvist M, Schatteman K, Leurs J, Verkerk R, Andersson JO, Johansson T, Scharpe S, Hendriks D. Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma. Thromb Haemost 2001; 85: 12–7.
  • Lanne B, Potthast F, Hoglund A, Brockenhuus von Lövenhielm H, Nystrom A-C, Nilsson F, Dahllöf B. Thiourea enhances mapping of the proteome from murine white adipose tissue. Proteomics 2001; 1: 819 — 28.
  • Schatteman KA, Goossens FJ, Scharpe SS, Hendriks DF. Proteolytic activation of purified human procarboxypeptidase U. Clin Chim Acta 2000; 292: 25–40.
  • Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic pro-perties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998; 58: 195–203.
  • Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, Chegini N. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 1996; 81: 3222–30.
  • Bouma BN, Marx PF, Mosnier LO, Meijers JC. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypepti-dase R, procarboxypeptidase U). Thromb Res 2001; 101: 329–54.
  • Schatteman KA, Goossens FJ, Scharpe SS, Neels HM, Hendriks DF. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma. Clin Chem 1999; 45: 807–13.
  • van Tilburg NH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 2000; 95: 2855— 9.
  • van Goor H, Bom VJ, van der Meer J, Sluiter WJ, Bleichrodt RP. Coagulation and fibrinolytic res-ponses of human peritoneal fluid and plasma to bacterial peritonitis. Br J Surg 1996; 83: 1133–5.
  • Boffa MC, Burke B, Haudenschild CC. Preserva-tion of thrombomodulin antigen on vascular and extravascular surfaces. J Histochem Cytochem 1987; 35: 1267–76.
  • Mosnier LO, Meijers JC, Bouma BN. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomo-dulin. Thromb Haemost 2001; 85: 5–11.
  • Hellebrekers BW, Trimbos-Kemper GC, Bakkum EA, Trimbos JB, Declerck PJ, Kooistra T, Emeis JJ. Short-term effect of surgical trauma on rat peri-toneal fibrinolytic activity and its role in adhesion formation. Thromb Haemost 2000; 84: 876–81.
  • Siebenlist KR, Mosesson MW. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis. J Biol Chem 1994; 269: 28414–9.
  • Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P. An inhi-bitor of activated thrombin-activatable fibrinoly-sis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model. Thromb Res 2000; 98: 333 —42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.